Stock Price
1.42
Daily Change
0.10 7.58%
Monthly
-27.18%
Yearly
-30.05%
Q1 Forecast
1.34

Autolus Therapeutics Ltd reported $24.91M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AstraZeneca USD 2.8B 328M Sep/2025
Autolus Therapeutics Ltd USD 24.91M 6.96M Jun/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 2.77M 136K Sep/2024